Results 41 to 50 of about 704,542 (298)

Uncertain magnitude of benefit of early second-generation androgen receptor antagonist treatment in advanced prostate cancer

open access: yesOncology Reviews
Guidelines currently recommend the early use of second-generation androgen receptor signaling inhibitors (ARSIs) in both castrate-resistant and -sensitive metastatic prostate cancer (with or without chemotherapy) and also in biochemical non-metastatic ...
Emma K. van de Weerdt   +8 more
doaj   +1 more source

An economic benefit evaluation model and its application for optimizing transmission capacity of multinational interconnections

open access: yesCSEE Journal of Power and Energy Systems, 2018
Multinational power grid interconnections play a critical part in supporting the vision of global energy internet. During the early stages of the Global Energy Internet, the value proposition of multinational interconnections should be carefully ...
Xiaojun Wang   +4 more
doaj   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho   +7 more
wiley   +1 more source

Paradigms in Operation: Pharmaceutical Benefit Assessments in England and Germany [PDF]

open access: yes, 2015
The assessment of the benefits of pharmaceutical products through health technology assessments (HTAs) has become a feature of health care decision-making in numerous OECD countries, including England and Germany.
Kieslich, K
core  

An exploration into early childhood physical literacy programs : a systematic literature review [PDF]

open access: yes, 2023
This review explored the impact of physical literacy programs designed to engage two- to five-year-old preschool children. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) was used.
Dabkowski, Elissa   +5 more
core   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Early childhood flexibility practices and patterns [PDF]

open access: yes, 2014
Executive summary The early childhood flexibility practices and patterns report highlights recommendations and future directions for early childhood education and care (ECEC) services in providing flexible arrangements for families and local ...

core  

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation [PDF]

open access: yes, 2014
Since the introduction of the German health care reform in January 2011, an early benefit assessment (EBA) is required for all new medicines. Pharmaceutical manufacturers have to submit a benefit dossier for evaluation by the Institute for Quality and ...
Schulenburg, Johann-Matthias Graf von der   +3 more
core   +2 more sources

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Home - About - Disclaimer - Privacy